US Patent

US9132110 — Treatment of pain with topical diclofenac

Method of Use · Assigned to HZNP Ltd · Expires 2027-10-17 · 1y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of using diclofenac for pain relief, including compositions such as solution and gel formulations.

USPTO Abstract

The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users.

Drugs covered by this patent

Arthrotec (Diclofenac Sodium) · Pfizer

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1488`	—	Arthrotec

Patent Metadata

Patent number: US9132110
Jurisdiction: US
Classification: Method of Use
Expires: 2027-10-17
Drug substance claim: No
Drug product claim: No
Assignee: HZNP Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.